首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Preparation of Biodegradable and Elastic Poly(ε-caprolactone-co-lactide) Copolymers and Evaluation as a Localized and Sustained Drug Delivery Carrier
【2h】

Preparation of Biodegradable and Elastic Poly(ε-caprolactone-co-lactide) Copolymers and Evaluation as a Localized and Sustained Drug Delivery Carrier

机译:可生物降解的弹性聚(ε-己内酯-丙交酯)共聚物的制备及其作为局部和持续药物输送载体的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To develop a biodegradable polymer possessing elasticity and flexibility, we synthesized MPEG-b-(PCL-co-PLA) copolymers (PCxLyA), which display specific rates of flexibility and elasticity. We synthesize the PCxLyA copolymers by ring-opening polymerization of ε-caprolactone and l-lactide. PCxLyA copolymers of various compositions were synthesized with 500,000 molecular weight. The PCxLyA copolymers mechanical properties were dependent on the mole ratio of the ε-caprolactone and l-lactide components. Cyclic tensile tests were carried out to investigate the resistance to creep of PCxLyA specimens after up to 20 deformation cycles to 50% elongation. After in vivo implantation, the PCxLyA implants exhibited biocompatibility, and gradually biodegraded over an eight-week experimental period. Immunohistochemical characterization showed that the PCxLyA implants provoked in vivo inflammation, which gradually decreased over time. The copolymer was used as a drug carrier for locally implantable drugs, the hydrophobic drug dexamethasone (Dex), and the water-soluble drug dexamethasone 21-phosphate disodium salt (Dex(p)). We monitored drug-loaded PCxLyA films for in vitro and in vivo drug release over 40 days and observed real-time sustained release of near-infrared (NIR) fluorescence over an extended period from hydrophobic IR-780- and hydrophilic IR-783-loaded PCxLyA implanted in live animals. Finally, we confirmed that PCxLyA films are usable as biodegradable, elastic drug carriers.
机译:为了开发具有弹性和柔韧性的可生物降解的聚合物,我们合成了MPEG-b-(PCL-co-PLA)共聚物(PCxLyA),该共聚物显示出特定的柔韧性和弹性率。我们通过ε-己内酯和l-丙交酯的开环聚合反应合成PCxLyA共聚物。合成了具有500,000分子量的各种组成的PCxLyA共聚物。 PCxLyA共聚物的机械性能取决于ε-己内酯和l-丙交酯组分的摩尔比。进行了循环拉伸试验,以研究PCxLyA试样在20个变形循环至50%伸长后的抗蠕变性。体内植入后,PCxLyA植入物表现出生物相容性,并在八周的实验期内逐渐被生物降解。免疫组织化学表征显示PCxLyA植入物引起体内炎症,随着时间的推移逐渐减少。该共聚物用作局部植入药物,疏水性药物地塞米松(Dex)和水溶性药物地塞米松21-磷酸二钠盐(Dex(p))的药物载体。我们监测了载药PCxL y A膜在40天内的体内和体外药物释放情况,并观察了长时间从疏水性IR-中实时持续释放近红外(NIR)荧光的情况。植入了780和亲水性IR-783的PC x L y A植入了活体动物。最后,我们确认PC x L y A膜可用作可生物降解的弹性药物载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号